Efficacy and Safety of WBRT Combined with Endostar in Patients with Advanced Non-Small Cell Lung Cancer

被引：0
|
作者：
Dong, Xiaorong [1 ]
Zhang, Ruiguang [1 ]
Goa, Xican [2 ]
Liu, Pian [2 ]
机构：
[1] Union Hosp, Canc Ctr, Wuhan, Hubei, Peoples R China
[2] Canc Ctr, Wuhan, Hubei, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
whole brain radiation therapy; non-small cell lung cancer; Brain metastasis; Endostar;
D O I：
10.1016/j.jtho.2016.11.1283
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.03b-002
引用
收藏
页码：S933 / S934
页数：2
相关论文
共 50 条
  • [21] Efficacy and safety of endostar combined with cisplatin in treatment of non-small cell lung cancer with malignant pleural effusion: A meta-analysis
    Hu, Yongqi
    Zhou, Zhenke
    Luo, Miao
    [J]. MEDICINE, 2022, 101 (52) : E32207
  • [22] Factors affecting the efficacy and safety of docetaxel combined with platinum in the treatment of advanced non-small cell lung cancer
    Wang, FengLi
    Zhao, ChenYang
    Wen, Xin
    Zheng, Qingshan
    Li, Lujin
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021, 14 (10) : 1295 - 1303
  • [23] Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab
    Jiang, Fenge
    Li, Junxia
    Kong, Xiangshuo
    Sun, Ping
    Qu, Huajun
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [24] Efficacy, safety, and prognostic factors of anlotinib treatment in advanced non-small cell lung cancer patients
    Huang, Aimi
    Wang, Weimin
    Qin, Ruoyan
    Chen, Guojie
    Gu, Aiqin
    Han, Baohui
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2022, 18 (05) : 1299 - +
  • [25] Efficacy and safety of second-line immunotherapy in patients with advanced non-small cell lung cancer
    Sanchez Escudero, Laura
    Cobelas Cartagena, Stephanie S.
    Sanchez Esperilla, Maria
    Bayo, Juan L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [26] Efficacy and Safety Evaluations of Anlotinib in Patients with Advanced Non-small Cell Lung Cancer Treated with Bevacizumab
    Jiang, F.
    Li, J.
    Kong, X.
    Qu, H.
    Sun, P.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S436 - S436
  • [27] The efficacy and safety of ramucirumab plus docetaxel in older patients with advanced non-small cell lung cancer
    Sakaguchi, Tadashi
    Furuya, Naoki
    Ito, Kentaro
    Hida, Naoya
    Morikawa, Kei
    Komase, Yuko
    Inoue, Takeo
    Hataji, Osamu
    Mineshita, Masamichi
    [J]. THORACIC CANCER, 2020, 11 (06) : 1559 - 1565
  • [28] Safety and efficacy of dostarlimab in patients (pts) with recurrent/advanced non-small cell lung cancer (NSCLC)
    Subramanian, J.
    Moreno, V.
    Bosch-Barrera, J.
    Pikiel, J.
    Kristeleit, R.
    Guo, W.
    Danaee, H.
    Im, E.
    Roda, D.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S886 - S887
  • [29] Efficacy and safety of apatinib monotherapy in elderly patients with advanced metastatic non-small cell lung cancer
    Li, Jian
    Tong, Xiwen
    Li, Hongtao
    [J]. INDIAN JOURNAL OF CANCER, 2020, 57 (01) : 13 - 17
  • [30] Evaluation of safety and efficacy of erlotinib as monotherapy for Chinese patients with advanced non-small cell lung cancer
    Zhang, Xiao-Tong
    Li, Long-Yun
    Wang, Meng-Zhao
    Zhang, Li
    Zhong, Wei
    Wang, Shu-Lan
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : 184 - 185
12345